Posted April 29, 2014
The FDA is taking steps to limit transparency and remove independent review of genetically engineered animals by disbanding its Veterinary Medicine Advisory Committee. The committee, composed of academics who peer review FDA’s risk analysis of GMO animals, met in 2010 when FDA initiated the approval process for the world’s first biotech food animal, GMO salmon. The agency has still not approved GMO salmon, probably in part because of how critical its invited scientists were. Read more.